>
SunLink Health Systems Inc logo

SSY - SunLink Health Systems Inc Share Price

$2.06 -0.2  -6.8%

Last Trade - 9:10pm

Sector
Consumer Defensives
Size
Micro Cap
Market Cap £11.1m
Enterprise Value £5.33m
Revenue £31.9m
Position in Universe 6250th / 6851
Bullish
Bearish
Unlock SSY Revenue
Momentum
Relative Strength (%)
1m -56.1%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -71.0%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Jun 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
73.7 63.4 53.3 45.2 45.6 47.8 -8.3%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 31 December 2020, SunLinkHealth Systems, Inc. revenues decreased 16% to $20.6M. Netincome before extraordinary items increased from $60K to$2.9M. Revenues reflect Pharmacy segment decrease of 14% to$13.7M, Healthcare Services segment decrease of 20% to$6.8M. Net income reflects Corporate Expense segment lossdecrease of 37% to $744K.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

SSY Revenue Unlock SSY Revenue

Net Income

SSY Net Income Unlock SSY Revenue

Normalised EPS

SSY Normalised EPS Unlock SSY Revenue

PE Ratio Range

SSY PE Ratio Range Unlock SSY Revenue

Dividend Yield Range

SSY Dividend Yield Range Unlock SSY Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
SSY EPS Forecasts Unlock SSY Revenue
Profile Summary

SunLink Health Systems, Inc., through its subsidiaries, owns businesses, which provide healthcare services in various markets in the United States. The Company's segments include Healthcare Facilities, Specialty Pharmacy, and Corporate and Other. Its Specialty Pharmacy segment is operated through its subsidiary, SunLink ScriptsRx, LLC (Scripts). As of June 30, 2016, its Healthcare Facilities segment subsidiaries owned and operated Trace Regional Hospital, which is a 84 bed community hospital and Floy Dyer Manor Nursing Home, which is a 66 bed nursing home in Mississippi, and Gilmer Nursing Home, which is a 100 bed nursing home in Georgia. As of June 30, 2016, the Specialty Pharmacy Segment subsidiary operated a specialty pharmacy business in Louisiana with four service lines. Its Specialty Pharmacy segment operates service lines, including retail pharmacy products and services; institutional pharmacy services; specialty pharmacy services, and durable medical equipment services.

Directors
Last Annual June 30th, 2020
Last Interim December 31st, 2020
Incorporated June 9, 1959
Public Since May 10, 2004
No. of Shareholders: 292
No. of Employees: 1,376
Sector Consumer Defensives
Industry Food & Drug Retailing
Index
Exchange NYSE MKT
Shares in Issue 6,899,321
Free Float (0.0%)
Eligible for
ISAs
SIPPs
SSY Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for SSY
Upcoming Events for SSY
Wednesday 12th May, 2021 Estimate
Q3 2021 SunLink Health Systems Inc Earnings Release
Monday 27th September, 2021 Estimate
Q4 2021 SunLink Health Systems Inc Earnings Release
Frequently Asked Questions for SunLink Health Systems Inc
What is the SunLink Health Systems Inc share price?

As of 9:10pm, shares in SunLink Health Systems Inc are trading at $2.06, giving the company a market capitalisation of £11.1m. This share price information is delayed by 15 minutes.

How has the SunLink Health Systems Inc share price performed this year?

Shares in SunLink Health Systems Inc are currently trading at $2.06 and the price has moved by 0.209k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the SunLink Health Systems Inc price has moved by 0.110k% over the past year.

What are the analyst and broker recommendations for SunLink Health Systems Inc?

There are no analysts currently covering SunLink Health Systems Inc.

When will SunLink Health Systems Inc next release its financial results?

SunLink Health Systems Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the SunLink Health Systems Inc dividend yield?

SunLink Health Systems Inc does not currently pay a dividend.

Does SunLink Health Systems Inc pay a dividend?

SunLink Health Systems Inc does not currently pay a dividend.

When does SunLink Health Systems Inc next pay dividends?

SunLink Health Systems Inc does not currently pay a dividend.

How do I buy SunLink Health Systems Inc shares?

To buy shares in SunLink Health Systems Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of SunLink Health Systems Inc?

Shares in SunLink Health Systems Inc are currently trading at $2.06, giving the company a market capitalisation of £11.1m.

Where are SunLink Health Systems Inc shares listed? Where are SunLink Health Systems Inc shares listed?

Here are the trading details for SunLink Health Systems Inc:

Country of listing: United States
Exchange: ASQ
Ticker Symbol: SSY
What kind of share is SunLink Health Systems Inc?

Based on an overall assessment of its quality, value and momentum, SunLink Health Systems Inc is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a SunLink Health Systems Inc share price forecast 2021?

We were not able to load any forecast data for SunLink Health Systems Inc.

How can I tell whether the SunLink Health Systems Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like SunLink Health Systems Inc. Over the past six months, the relative strength of its shares against the market has been 58.29%. At the current price of $2.06, shares in SunLink Health Systems Inc are trading at 56.69% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the SunLink Health Systems Inc PE Ratio?

We were not able to find PE ratio data for SunLink Health Systems Inc.

Who are the key directors of SunLink Health Systems Inc?

SunLink Health Systems Inc's management team is headed by:

Robert Thornton - CHM
Mark Stockslager - CFO
Howard Turner - IND
C. Ford - IND
Steven Baileys - IND
Gene Burleson - IND
Byron Finn - CEX
Who are the major shareholders of SunLink Health Systems Inc?

Here are the top five shareholders of SunLink Health Systems Inc based on the size of their shareholding:

Baileys (Steven J) Individual Investor
Percentage owned: 11.64% (803k shares)
Thornton (Robert M Jr) Individual Investor
Percentage owned: 7.59% (523k shares)
Turner (Howard E) Individual Investor
Percentage owned: 5.47% (378k shares)
Berggruen Holdings, Inc. Private Equity
Percentage owned: 5.43% (375k shares)
Wittenberg Investment Management Inc Investment Advisor
Percentage owned: 4.67% (322k shares)
Similar to SSY
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.